As a biotechnology company, Vascudyne is a leading center of excellence for developing and manufacturing engineered tissue. They offer unique engineered tissue-based device designs, manufacturing capabilities, technical expertise, and product development support to their clients. Vascudyne's focus is on developing tissue-based coronary bypass grafts to accelerate the commercialization of their technology and make it available to surgeons, ultimately benefiting patients in need of replacement and repair tissues.